Remove Gene Remove Genome Project Remove Marketing
article thumbnail

Realising the promise of genomic testing across oncology

pharmaphorum

Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.

Genome 52
article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

Rather than be provided a therapy that has been tested across a broad range of the population, there are now many therapies on the market that are designed specifically to work for sub-populations within disease areas. The information gathered from the project is still providing insights today, a decade later.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Spatial Genomics, Transcriptomics and Proteomics Solutions – An Amelioration of Tissue Analytics

Roots Analysis

Furthermore, several live cell imaging and non-destructive fluorescence histological methods measure limited number of biomarkers at a time and the tags introduced may interfere with the natural function of genes and proteins. Likely Growth of the Spatial Omics Solutions Market. The trend is unlikely to change in the foreseen future.

Genome 52
article thumbnail

New research across its oncology portfolio at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021

The Pharma Data

and European Union (EU) approvals, will also be presented, including long-term outcomes in patients with TRK fusion cancer receiving larotrectinib and data from the 100,000 Genomes Project analyzing the prognostic factor for survival for patients with tumors that harbor a neurotrophic receptor tyrosine kinase ( NTRK ) gene fusion.

article thumbnail

Nutrigenomics: The Future of Personalized Nutrition

Roots Analysis

According to a study, around 20,000 genes are present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. Nutrigenomics is the science studying the relationship between human genome, nutrition and health. Figure below presents an overview of nutrigenomics.

Genome 40
article thumbnail

CRISPR therapies targeting the next breakthrough in oncology

pharmaphorum

The potential to develop treatments with CRISPR gene editing is hinged on its ability to add, delete or replace elements within a target DNA sequence. Cancer is a genetic disease, caused by certain changes in the way that genes control cell function, such as how they grow and divide. The pipeline.

article thumbnail

A history of blood cancer treatment

pharmaphorum

Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. 2012 – The 100,000 Genomics Project begins. 2016–2022 — New treatments enter the market.